Navigation Links
UPDATE: Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Behavioral Symptoms of Autism



NIXA, Mo., May 19 /PRNewswire-USNewswire/ -- A primate model for autism using the U.S. children's immunization schedule was unveiled at the International Meeting For Autism Research (IMFAR) this weekend. The research underscores the critical need for studies into vaccine safety and the immune and mitochondrial dysfunction of autistic children. The National Autism Association (NAA) questions why the government hasn't undertaken these vital studies and why researchers have had to depend on private money to perform this critical science that will surely impact the health of millions of children worldwide.

While the authors and organizations associated with this study are withholding comment until publication, University of Pittsburgh's Dr. Laura Hewitson, Ph.D., described at the IMFAR meeting how vaccinated animals, when compared to unvaccinated animals, showed significant neurodevelopmental deficits and "significant associations between specific aberrant social and non-social behaviors, isotope binding, and vaccine exposure."

Researchers also reported at the scientific meeting that "vaccinated animals exhibited progressively severe chronic active inflammation whereas unexposed animals did not" and found "many significant differences in the GI tissue gene expression profiles between vaccinated and unvaccinated animals." Gastrointestinal issues are a common symptom of children with regressive autism.

NAA calls for the NIH to conduct large scale, non-epidemiological studies into the biomedical symptoms surrounding young children and all vaccines, including those containing the mercury-based preservative thimerosal and other additives like aluminum.

This request for further research echoes that of Dr. Bernadine Healy, Former NIH Director in a CBS interview earlier this week. "I think public health officials have been too quick to dismiss the hypothesis as 'irrational,' without sufficient studies of causation... without studying the population that got sick," Healy said. "I have not seen major studies that focus on 300 kids who got autistic symptoms within a period of a few weeks of the vaccines."

Recently the government's vaccine court conceded the case of Hannah Poling, admitting that vaccines triggered her regression into autism by exacerbating mitochondrial dysfunction. "The recent Poling case and this new research provide further evidence that the CDC has fallen down on their job to protect children from harm. The biomedical research to date suggests that parental reports of regression following vaccination is not only plausible, but likely in certain individuals," said Scott Bono, NAA Chairman. "To date, the CDC has conducted no safety testing on the possible harmful effects of simultaneously administering multiple vaccines to infants, and has steadfastly refused to state a preference for mercury-free vaccines to be given to children and pregnant women. It's time for HHS and Congress to step in and take vaccine safety away from the CDC."

On June 4th, parents of vaccine-injured children will rally for toxin-free immunizations in Washington, DC. For more information visit


Wendy Fournier (Portsmouth, RI) 401-835-5828

Rita Shreffler (Nixa, MO) 401-632-6452

SOURCE National Autism Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
2. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
3. UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure
4. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
5. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
6. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
7. Pregnant Women Need Omega-3 to Boost Infant Development
8. Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities
9. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
10. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
11. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... 7th Annual 2015 Golden Bridge Business Awards under the New Products and Services ... capex web based sample management software that helps labs organize data ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech North ... Gary has spent a significant amount of time in Sweden since joining PartnerTech ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani ... Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled ... Contact Center solutions targeted to the high-end enterprise contact center marketplace. , Ed ...
Breaking Medicine News(10 mins):